VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury
- 1 December 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 295 (6), F1648-F1657
- https://doi.org/10.1152/ajprenal.00099.2008
Abstract
Acute kidney injury induced by renal ischemia-reperfusion (I/R) compromises microvascular density and predisposes to chronic kidney disease (CKD) and sodium-dependent hypertension. VEGF-121 was administered to rats fed a standard (0.4%) sodium diet at various times following recovery from I/R injury for up to 35 days. VEGF-121 had no effect on the initial loss of renal function, as indicated by serum creatinine levels measured 24 h after injury. Serum creatinine levels declined thereafter, indicative of renal repair. Rats were then switched to an elevated (4.0%) sodium diet for an additional 28 days to induce CKD. The 4.0% sodium diet enhanced renal hypertrophy, interstitial volume, albuminuria, and cardiac hypertrophy relative to postischemic animals maintained on the 0.4% sodium diet. Administration of VEGF-121 from day 0 to 14, day 0 to 35, or day 3 to 35 after I/R suppressed the effects of sodium diet on CKD development, while delayed administration of VEGF-121 from day 21 to 35 had no effect. Endothelial nitric oxide synthase protein levels were upregulated in postischemic animals, and this effect was significantly increased by the 4.0% sodium diet but was not influenced by prior treatment with VEGF. Conversely, microvascular density was preserved in postischemic animals treated with VEGF-121 relative to vehicle-treated postischemic animals. These data suggest that early, but not delayed, treatment with VEGF-121 can preserve vascular structure after ischemia and influence chronic renal function in response to elevated sodium intake.Keywords
This publication has 35 references indexed in Scilit:
- Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitorAmerican Journal of Physiology-Renal Physiology, 2008
- Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failureAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- The endothelial cell in ischemic acute kidney injury: implications for acute and chronic functionKidney International, 2007
- Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertensionAmerican Journal of Physiology-Renal Physiology, 2006
- Transforming growth factor-β in acute renal failure: receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injuryAmerican Journal of Physiology-Renal Physiology, 2005
- Angiostatin and matrix metalloprotease expression following ischemic acute renal failureAmerican Journal of Physiology-Renal Physiology, 2004
- Rat cerebellar granule cells are protected from glutamate-induced excitotoxicity byS-nitrosoglutathione but not glutathioneAmerican Journal of Physiology-Cell Physiology, 2004
- Mechanisms of Renal Cell Repair and Regeneration after Acute Renal FailureThe Journal of pharmacology and experimental therapeutics, 2002
- Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathyKidney International, 2001
- Influence of Dietary Sodium Intake on Renal Medullary Nitric Oxide SynthaseHypertension, 1996